#293: Professor Thomas Seyfried - A New Approach For Fighting Cancer

Professor Thomas Seyfried is an American professor of biology, genetics, and biochemistry at Boston College. He received his PhD from the University of Illinois Urbana-Champaign in 1976. His postdoctoral fellowship studies were in the Department of Neurology at the Yale University School of Medicine where he served as an assistant professor in neurology. Professor Seyfried's research focuses on mechanisms of chronic diseases such as cancer, epilepsy, neurodegenerative lipid storage diseases, and caloric restriction diets. Prof. Seyfried has been published in over 150 peer-reviewed publications. He previously served as chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro. His 2012 book is Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. In this episode today, Prof. Seyfried, and I discuss: - What is cancer? - Current outlooks for cancer treatments - The causes of cancer - Metabolic therapy vs other forms of cancer treatment - Empirical data for metabolic therapy - Common rebuttals to metabolic therapy - Water only fasting vs the keto diet - Cancer prevention & more! Connect with us: https://freedompact.co.uk/newsletter​ (Healthy, Wealthy & Wise Newsletter) https://instagram.com/freedompact​ tiktok.com/personaldevelopment https://twitter.com/freedompactpod freedompact@gmail.com Connect with Prof. Seyfried: https://cancerevolution.film https://www.bc.edu/bc-web/schools/mca... DISCLAIMER: The content provided by the Freedom Pact Podcast is for educational and entertainment purposes only. Our content is not intended to constitute or be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on our social media or other platforms.